IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Bernardi, Simona
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.414
AS - Asia 4.193
EU - Europa 3.939
SA - Sud America 765
AF - Africa 97
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 3
Totale 16.426
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.252
SG - Singapore 1.650
CN - Cina 1.172
IT - Italia 903
PL - Polonia 657
BR - Brasile 651
DE - Germania 544
UA - Ucraina 513
HK - Hong Kong 446
FI - Finlandia 312
VN - Vietnam 279
GB - Regno Unito 221
RU - Federazione Russa 180
TR - Turchia 176
FR - Francia 144
IN - India 132
IE - Irlanda 125
CA - Canada 86
SE - Svezia 85
BD - Bangladesh 72
CZ - Repubblica Ceca 56
MX - Messico 50
JP - Giappone 46
IQ - Iraq 44
AR - Argentina 42
ZA - Sudafrica 42
ES - Italia 36
NL - Olanda 35
BE - Belgio 31
AT - Austria 22
ID - Indonesia 21
EG - Egitto 17
EC - Ecuador 16
TH - Thailandia 15
AU - Australia 14
SA - Arabia Saudita 14
UZ - Uzbekistan 14
VE - Venezuela 14
DK - Danimarca 13
IR - Iran 13
CO - Colombia 12
IL - Israele 12
MA - Marocco 12
AE - Emirati Arabi Uniti 11
LT - Lituania 11
JO - Giordania 9
KR - Corea 9
LK - Sri Lanka 9
PY - Paraguay 9
AZ - Azerbaigian 7
GR - Grecia 7
KE - Kenya 7
PE - Perù 7
PT - Portogallo 7
BO - Bolivia 6
ET - Etiopia 6
MY - Malesia 6
PK - Pakistan 6
CH - Svizzera 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
OM - Oman 5
PA - Panama 5
BG - Bulgaria 4
CL - Cile 4
HR - Croazia 4
LV - Lettonia 4
PS - Palestinian Territory 4
SK - Slovacchia (Repubblica Slovacca) 4
CU - Cuba 3
DZ - Algeria 3
EU - Europa 3
HN - Honduras 3
HU - Ungheria 3
LB - Libano 3
NP - Nepal 3
RO - Romania 3
TN - Tunisia 3
UY - Uruguay 3
AO - Angola 2
BB - Barbados 2
EE - Estonia 2
JM - Giamaica 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
MK - Macedonia 2
MU - Mauritius 2
PH - Filippine 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
CG - Congo 1
CI - Costa d'Avorio 1
GY - Guiana 1
IM - Isola di Man 1
MS - Montserrat 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
Totale 16.422
Salva come PNG Salva come JPEG
Città #
Ashburn 791
Singapore 743
Fairfield 710
Warsaw 642
Woodbridge 457
Hong Kong 444
Chandler 372
Jacksonville 354
Beijing 331
New York 322
Houston 316
Seattle 298
Wilmington 273
Ann Arbor 270
Cambridge 264
Brescia 239
Princeton 219
Los Angeles 191
Munich 191
Helsinki 188
Dallas 161
Des Moines 125
Istanbul 124
Dublin 123
The Dalles 111
Ho Chi Minh City 98
Shanghai 98
San Francisco 79
São Paulo 75
Milan 72
Nanjing 72
Boardman 71
Turku 70
Redondo Beach 65
Buffalo 61
Moscow 60
Chicago 56
Hanoi 53
Brooklyn 50
Santa Clara 48
San Diego 47
Dearborn 46
Brno 41
London 39
Nanchang 39
Tokyo 38
Changsha 37
Tianjin 37
Orem 36
Pune 36
Jinan 32
Nuremberg 32
Denver 31
Rome 31
Brussels 30
Toronto 30
Johannesburg 28
Shenyang 27
Frankfurt am Main 24
Atlanta 23
Montreal 22
Poplar 22
Phoenix 21
Romola 21
Stockholm 21
Guangzhou 20
Lappeenranta 20
Mexico City 20
Boston 19
Jiaxing 19
Ningbo 19
Baghdad 18
Chennai 18
Dong Ket 18
Rio de Janeiro 18
Charlotte 17
Genoa 17
Belo Horizonte 16
Hebei 16
Manchester 16
Verona 16
Brasília 15
Düsseldorf 15
Amsterdam 14
Zhengzhou 14
Ankara 13
Bologna 13
Curitiba 13
Hangzhou 13
Jakarta 13
Kocaeli 13
Barlassina 12
Falkenstein 12
Helsingør 12
Tashkent 12
Wroclaw 12
Olomouc 11
Querétaro 11
Biên Hòa 10
Da Nang 10
Totale 10.603
Salva come PNG Salva come JPEG
Nome #
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 294
BACTERIAL BLOOD STREAM INFECTIONS NEGATIVELY IMPACT ON OUTCOME OF PATIENTS TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION: 6 YEARS SINGLE-CENTRE EXPERIENCE 278
Postremission sequential monitoring of minimal residual disease by WT1 Q-PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk-adapted therapy in acute myeloid leukemia patients 271
Circulating endothelial cell count: a reliable marker of endothelial damage in patients undergoing hematopoietic stem cell transplantation 260
“Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay.” Is dPCR the key? 232
Zebrafish disease models in hematology: Highlights on biological and translational impact 218
Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery 193
A specific Toll-like receptor profile on T lymphocytes and values of monocytes correlate with bacterial, fungal, and cytomegalovirus infections in the early period of allogeneic stem cell transplantation 185
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 185
3D gelatin-chitosan hybrid hydrogels combined with human platelet lysate highly support human mesenchymal stem cell proliferation and osteogenic differentiation 178
Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years 176
Targeting HRASV12G Expression to the Zebrafish Early Hemogenic Progenitors Induces a Myeloproliferative Disorder by Repressing the Notch Pathway. 176
Rational Design and Development of Anisotropic and Mechanically Strong Gelatin-Based Stress Relaxing Hydrogels for Osteogenic/Chondrogenic Differentiation 168
Alterations of AQP2 expression in trigeminal ganglia in a murine inflammation model 166
Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data 165
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 162
SIRPB1 Is a Strong Predictor Biomarker of Response to 5-Azacitidine Therapy in MDS and AML Patients 158
TARGETING HRASV12G EXPRESSION TO THE ZEBRAFISH EARLY HEMOGENIC PROGENITORS INDUCES A MYELOPROLIFERATIVE DISORDER BY REPRESSING THE NOTCH PATHWAY. 157
Clinical Care of Hematological Patients in a Bone Marrow Transplant Unit: Do Human Resources Influence Infection Incidence? 157
A Gene Panel NGS-Based Strategy for Genomic Characterization of Acute Myeloid Leukemias (AMLs) 155
Comparative Somatic Mutational Profiling of CD34+ Hematopoietic Precursors (HSC) and Circulating Endothelial Cells (CEC) in Patients with Primary Myelofibrosis (PMF) 154
Multidimensional Geriatric Assessment for Elderly Patients (≥60 years) Submitted for Allogeneic Stem Cell Transplantation. a French (Paris) - Italian (Brescia) 10-Years Experience on 228 Patients 147
Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation 144
Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR4.0, MR4.5 And MR5.0) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR) 144
MULTI-GENOTYPING OF MINOR HISTOCOMPATIBILITY ANTIGENS (MHAGS) IN ALLOGENEIC STEM CELL TRANSPLANTATION AND THEIR ROLE IN DETERMINING GRAFT VERSUS HOST DISEASE (GVHD) AND GRAFT VERSUS LEUKEMIA (GVL) EFFECT. 142
Development of BCR-ABL1 Transgenic Zebrafish Model Reproducing Chronic Myeloid Leukemia (CML) Like-Disease and Providing a New Insight into CML Mechanisms 142
Advances in CMV Management: A Single Center Real-Life Experience 140
Development of a cell culture model based on biocompatible polymeric scaffolds engineered with human Mesenchymal Stromal Cells (MSCs) for cartilage and bone regenerative therapy 139
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS 138
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review 137
First Interim Report of the Italian Multicentric Phase-III Randomized Study to Optimize TKIs Multiple Approaches - (OPTkIMA) in Elderly Patients (older than 60 years) with Ph+ Chronic Myeloid Leukemia (CML) and MR3.0/ MR4.0 Stable Molecular Response 136
Chitosan-Hydrogel Polymeric Scaffold Acts as an Independent Primary Inducer of Osteogenic Differentiation in Human Mesenchymal Stromal Cells 136
Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment 134
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner? 131
RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients? 130
Parameters of Protein Metabolism and Thyroid Function As Predictors in a Scoring System for Acute and Chronic Graft-Versus-Host Disease 129
Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach 129
3D-MAPPING OF MESENCHYMAL STEM CELLS GROWTH ON BIOENGINEERED SCAFFOLDS FOR MAXILLOFACIAL SKELETON REGENERATION: A PRECLINICAL, IN VITRO STUDY 126
Index of Bone Marrow Output and Imbalance of B-Lymphocyte Homeostasis before and after Transplantation Correlate Differently with Graft-Versus-Host Disease and Relapse 125
Bioengineered scaffolding for mandibular reconstruction: a preclinical, xenograft animal study 125
Parameters of Protein Metabolism and Thyroid Function As Predictors in a Scoring System for Acute and Chronic Graft-Versus-Host Disease 123
CT-290: Clinical Frailty Scale as a Novel Tool to Evaluate Patients’ Eligibility for Allogeneic Stem Cell Transplant: A Single-Center Experience on 234 Patients >50 Years Old 123
Peripheral Blood WT1 Expression Predicts Relapse in AML Patients Undergoing Allogeneic Stem Cell Transplantation. 122
ETV6: A Candidate Gene for Predisposition to “Blend Pedigrees”? A Case Report from the NEXT-Famly Clinical Trial 120
Comparative Study on Fresenius-ATG Versus Thymoglobuline-ATG for the Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation from Matched Unrelated Donor: A Single Center Experience on 76 Patients 120
A NEW PROMISING APPROACH TO PERFORM HLA TYPING IN A QUICKLY, SIMPLE AND ACCURATE WAY: THE PYROSEQUENCING 117
The role of allogeneic hematopoietic stem cell transplantation in the four P medicine era 115
Genomic Analysis Of Notch Mutations In a Case Of Alagille Syndrome With Acute Lymphoblastic Leukemia 115
Sequential monitoring of lymphocyte subsets and of T-and-B cell neogenesis indexes to identify time-varying immunologic profiles in relation to graft-versus-host disease and relapse after allogeneic stem cell transplantation 115
WT1 Monitoring of Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukemia. 114
PYROSEQUENCING IS A NEW PROMISING APPROACH TO PERFORM HLA TYPING IN A QUICKLY, SIMPLE AND ACCURATE WAY. 114
Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French-Italian 10-year experience on 228 patients 113
Comparative monitoring of deep molecular response (DMR) by RT-quantitative (RT-qPCR) and digital PCR (dPCR) in Ph+ Chronic Myeloid Leukemia (CML) patients treated with TKIs for recognition of stable deep molecular response (DMR) and identification of best candidates to TKIs treatment discontinuation. 112
Mineralization of 3D Osteogenic Model Based on Gelatin-Dextran Hybrid Hydrogel Scaffold Bioengineered with Mesenchymal Stromal Cells: A Multiparametric Evaluation 112
ACHIEVEMENT OF COMPLETE REMISSION WITH PONATINIB THERAPY FOR PHILADELPHIA ACUTE LYMPHOBLASTIC LEUKEMIA RELAPSED AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: A CASE REPORT. 111
Digital PCR (Dpcr) a Step Forward to Detection and Quantification of Minimal Residual Disease (MRD) in Ph+/BCR-ABL1 Chronic Myeloid Leukemia (CML) 111
OPTIMIZATION OF TKI TREATMENT IN ELDERLY PATIENTS WITH PH+ CHRONIC MYELOID LEUKEMIA AND STABLE MR3.0 OR MR4.0: 1ST YEAR RESULTS OF THE ITALIAN MULTICENTRIC PHASE-III RANDOMIZED OPTKIMA STUDY 111
Safety and Efficacy of ATG-based GvHD prophylaxis in allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome: a single center experience 111
When Less Is More: Specific Capture and Analysis of Tumor Exosomes in Plasma Increases the Sensitivity of Liquid Biopsy for Comprehensive Detection of Multiple Androgen Receptor Phenotypes in Advanced Prostate Cancer Patients 110
IN VIVO STUDY (MYCEC0617) OF CD34+-HSC AND CEC MUTATIONAL PROFILE FOR INVESTIGATING CELL ORIGIN AND PATHOGENESIS OF PRIMARY MYELOFIBROSIS (PMF) 110
Invasive pulmonary aspergillosis in acute leukemia: a still frequent condition with a negative impact on the overall treatment outcome 108
Digital PCR (dPCR) Overcomes the Limitations in Detection and in Quantification of Quantitative PCR (qPCR) and Reveals Different Levels of BCR-ABL1 Copies/µl Among the Chronic Myeloid Leukemia (CML) Patients Achieving Major (MR3.0) or DEEP (MR4.0, MR4.5 and MR5.0) Molecular Response with Tyrosin Kynase Inhibitors (TKIs) 107
DIGITAL PCR IN PH plus CHRONIC MYELOID LEUKEMIA PATIENTS FOR RECOGNITION OF "STABLE" DEEP MOLECULAR RESPONSE AND IDENTIFICATION OF BEST CANDIDATES TO TKI DISCONTINUATION 107
Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey) 107
Successful hematopoietic stem cell transplantation for complete CTLA-4 haploinsufficiency due to a de novo monoallelic 2q33.2-2q33.3 deletion 107
P1450: AUTOLOGOUS STEM CELL TRANSPLANTATION INDUCES HIGHER LEVEL OF EXHAUSTED T-CELLS IN DLBCL PATIENTS BEFORE LEUKAPHERESIS FOR CAR-T CELL THERAPY 106
Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case? 106
Extracellular Vesicles: From Biomarkers to Therapeutic Tools 104
Abstract A27: European Network NGS-PTL preliminary data: Whole exome sequencing identifies mutations of ALDH2, RETSAT, HSPG2, CHPF and other metabolic genes as a novel functional category in acute myeloid leukemia 104
AZACITIDINE (AZA) FOR RELAPSED HIGH RISK MYELODYSPLASIC SYNDROME AFTER INTRABONE CORD BLOOD TRANSPLANTATION: A CASE REPORT. 103
COMBINED EFFECTS OF MESENCHYMAL STROMAL CELLS (MSC) AND STIMULATORY CYTOKINES ON THE ex vivo GROWTH OF UMBILICAL CORD BLOOD HEMATOPOIETIC PROGENITOR CELLS (UCB-HPC) 103
PROGNOSTIC RELEVANCE OF WT1 MOLECULAR LEVELS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION. 102
EXTRACORPOREAL PHOTOPHERESIS (ECP) FOR TREATEMENT OF ACUTE AND CHRONIC GRAFT VERSUS HOST DISEASE: AN ITALIAN MULTICENTRIC RETROSPECTIVE ANALYSIS ON 94 PATIENTS ON BEHALF OF THE GRUPPO ITALIANO TRAPIANTO DI MIDOLLO OSSEO (GITMO) 102
THE PYROSEQUENCING: A NEW PROMISING APPROACH TO PERFORM HLA TYPING AND SELECT THE STEM CELL DONOR IN A QUICKLY, SIMPLE AND ACCURATE WAY 101
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 100
Single step multiple genotyping by MALDI-TOF mass spectrometry, for evaluation of minor histocompatibility antigens in patients submitted to allogeneic stem cell transplantation from HLA-matched related and unrelated donor 99
EARLY EXTRACORPOREAL PHOTOAPHERESIS FOR THE TREATMENT OF ACUTE GRAFT VERSUS HOST DISEASE (AGVHD). 98
Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Level. Comparison of Qpcr, d-PCR and CD26 Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR) 98
Aggressive Aneuploid Acute Myeloid Leukemia Is Dependent on Alterations of P53, Gain of APC and PLK1 and Loss of RAD50 98
Different In Vitro Models of Chronic Myeloid Leukemia Show Different Characteristics: Biological Replicates Are Not Biologically Equivalent 96
Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol) 96
Detection of newly produced T and B lymphocytes by digital PCR in blood stored dry on nylon flocked swabs 95
Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection 93
PB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T- CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA 93
Exosomes in Chronic Myeloid Leukemia: Are We Reading a New Reliable Message? 92
Severe Acute Respiratory Syndrome Coronavirus-2 Pandemia: Facts and Perspectives in a Bone Marrow Transplant Unit 92
Comparative Mutational Profiling of Hematopoietic Progenitor Cells and Circulating Endothelial Cells (CECs) in Patients with Primary Myelofibrosis 92
MULTI-GENOTYPING OF MINOR HISTOCOMPATIBILITY ANTIGENS (MHAGS) TO EVALUATE THEIR ROLE IN DETERMINING GRAFT VERSUS HOST DISEASE (GVHD) AND GRAFT VERSUS LEUKEMIA (GVL) EFFECTS IN ALLOGENEIC STEM CELL TRANSPLANTATION 91
Molecular Testing in CML between Old and New Methods: Are We at a Turning Point? 91
FAILURE TO REPLICATE THE ASSOCIATION OF UROMODULIN GENE VARIANT RS 13333226 WITH HYPERTENSION IN A GENERAL POPULATION STUDY 90
BRENTUXIMAB SALVAGE THERAPY IN HODGKIN LYMPHOMA PATIENTS RELAPSED AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE. 90
MULTI-GENOTYPE OF MINOR HISTOCOMPATIBILITY ANTIGENS (MHAGS) TO STUDY GRAFT VERSUS HOST DISEASE (GVHD) AND GRAFT VERSUS LEUKEMIA (GVL) EFFECTS IN ALLOGENEIC STEM CELL TRANSPLANTATION. 90
Timely Leukapheresis May Interfere with the “Fitness” of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL Patients 89
A Systematic Review of the Literature and Perspectives on the Role of Biomarkers in the Management of Malnutrition After Allogeneic Hematopoietic Stem Cell Transplantation 89
Achievement of complete remission with Ponatinib therapy for Philadelphia positive acute lymphoblastic leukemia relapsed after allogeneic stem cell transplantation: a case report 89
Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2) 88
Nutritional intervention with TGF-beta enriched food for special medical purposes (TGF-FSMP) is associated with a reduction of malnutrition, acute GVHD, pneumonia and may improve overall survival in patients undergoing allogeneic hematopoietic stem transplantation 88
Favourable/Intermediate ELN-Risk Acute Myeloid Leukemia to Transplant or Not to Transplant First-Line? 88
Stratification of Oligometastatic Prostate Cancer Patients by Liquid Biopsy: Clinical Insights from a Pilot Study 87
Alignment of Qx100/Qx200 Droplet Digital (Bio-Rad) and QuantStudio 3D (Thermofisher) Digital PCR for Quantification of BCR-ABL1 in Ph+ Chronic Myeloid Leukemia 87
Totale 12.827
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.784
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.784
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.272 0 0 0 0 0 230 70 214 161 326 168 103
2021/20221.059 89 100 44 63 39 75 52 73 63 143 75 243
2022/20231.112 154 48 45 84 113 229 8 121 165 16 64 65
2023/20241.539 71 32 121 86 92 368 85 77 260 26 41 280
2024/20253.578 61 77 50 390 291 279 236 167 561 277 675 514
2025/20264.304 666 796 497 980 860 505 0 0 0 0 0 0
Totale 16.774